English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17775/20116 (88%)
Visitors : 9535508      Online Users : 361
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31760

    標題: Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study
    作者: Huang, Chung-I
    Lin, Li-Ching
    Tien, Hung-Cheng
    Que, Jenny
    Ting, Wei Chen
    Chen, Po-Chun
    Wu, Hsin-Min
    Ho, Chung-Han
    Wang, Jhi-Joung
    Wang, Ren-Hong
    Yang, Ching-Chieh
    貢獻者: E Da Canc Hosp, Dept Radiat Oncol
    Chi Mei Med Ctr, Dept Radiat Oncol
    Minist Hlth & Welf, Pingtung Hosp, Dept Psychiat
    Pingtung Christian Hosp, Dept Radiat Oncol
    Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med,Natl Cheng Kung Univ Hosp
    Chi Mei Med Ctr, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Chi Mei Med Ctr, Dept Clin Pathol
    Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol
    Natl Sun Yat Sen Univ, Inst Biomed Sci
    Chia Nan Univ Pharm & Sci, Dept Biotechnol
    關鍵字: Quality-Of-Life
    Metabolic Syndrome
    日期: 2017-03-31
    上傳時間: 2018-11-30 15:55:40 (UTC+8)
    出版者: Public Library Science
    摘要: Objective Anxiety/depression is common among patients with head and neck cancer (HNC), and can negatively affect treatment compliance and outcome. The aim of this study was to assess the association between hyperlipidemia and the risk of new-onset anxiety/depression after the diagnosis of HNC and the influence of administering statins. Methods A matched longitudinal cohort study of 1632 subjects (408 HNC patients with preexisting hyperlipidemia and 1224 age- and sex-matched HNC patients without hyperlipidemia) was included and analyzed by using data from Taiwan's National Health Insurance Research Database from January 1996 to December 2012. The incidence and hazard ratios (HRs) for the development of new-onset anxiety/depression were examined between the two groups. Cox proportional hazard regression was applied to estimate the relative risks of anxiety/depressive disorders adjusted for potential confounding factors. To estimate the risks of anxiety/depression in different sub-groups, a stratified analysis was also used. Results HNC patients with preexisting hyperlipidemia had a higher risk for comorbidities such as hypertension, diabetes mellitus, and cardiovascular disease (P <0.001). The incidence rate of anxiety/depression in the HNC patients with preexisting hyperlipidemia was also significantly higher than that among patients without hyperlipidemia (10.78% vs 7.27%, respectively; P = 0.03). A Cox regression model revealed that preexisting hyperlipidemia was an independent risk factor for anxiety/depression (aHR, 1.96; 95% CI, 1.30-2.94). Statins use was protective against anxiety/depression among HNC patients with hyperlipidemia ( aHR, 0.85; 95% CI, 0.46-1.57), especially for individuals older than 65 years and for females. Conclusions Preexisting hyperlipidemia was associated with increased risk of new-onset anxiety/depression in the HNC patients. Statins use for HNC patients with hyperlipidemia could decrease the risk of anxiety/depression, especially for those older than 65 years and for female patients.
    關聯: Plos One, v.12, n.3, e0174574
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    journal.pone.0174574.pdf1032KbAdobe PDF0View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback